TEST CATALOG ORDERING & RESULTS SPECIMEN HANDLING CUSTOMER SERVICE EDUCATION & INSIGHTS
Test Catalog

Test ID: PHI11    
Prostate Health Index (phi), Serum

Useful For Suggests clinical disorders or settings where the test may be helpful

Aids in distinguishing prostate cancer from benign prostate conditions in men with total prostate-specific antigen (PSA) concentrations in the 4 to 10 ng/mL range and digital rectal examination (DRE) findings that are not suspicious for cancer

Reflex Tests Lists tests that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial tests.

Test IDReporting NameAvailable SeparatelyAlways Performed
PHI13Prostate Health Index (phi)NoNo

Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests.

This test begins with the analysis of prostate-specific antigen (PSA). If the PSA is between 2.0 and 10.0 ng/mL, then the reflex test (PHI13) will be performed.

 

If the initial PSA is between 2.0 and 10.0 ng/mL, then free PSA and [-2]ProPSA will be reported.

If the initial PSA is between 4.0 and 10.0 ng/mL, then the percent free PSA and prostate health index (phi) will be calculated and reported.

If the initial PSA is between 2.0 and 4.0 ng/mL, then the percent free PSA and prostate health index (phi) will not be calculated or reported.

Method Name A short description of the method used to perform the test

Immunoenzymatic Assay

NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name Lists a shorter or abbreviated version of the Published Name for a test

Prostate Health Index (phi), S

Aliases Lists additional common names for a test, as an aid in searching

P2PSA
PHI
Prostate Health Index
Pro-2-PSA